UK Study Integrates PrecivityAD2 Blood Test for Alzheimer’s in Primary Care
Researchers in the United Kingdom are integrating the PrecivityAD2 blood test from C2N Diagnostics into the Alzheimer’s disease…
Codex Genetics Partners with C2N Diagnostics to Introduce the PrecivityAD2™ Blood Test in Hong Kong, Facilitating Access to Innovative Alzheimer’s Disease Diagnostics
HONG KONG, March 10, 2026 /PRNewswire/ — Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong,…